Related references
Note: Only part of the references are listed.Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer
Benjamin Tournier et al.
CANCERS (2023)
DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer
Huichuan Yu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)
Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer
Zhen Ye et al.
BMC CANCER (2023)
CoSMeD: a user-friendly web server to estimate 5-year survival probability of left-sided and right-sided colorectal cancer patients using molecular data
Junyi Xin et al.
BIOINFORMATICS (2022)
DNA methylation-based predictors of health: applications and statistical considerations
Paul D. Yousefi et al.
NATURE REVIEWS GENETICS (2022)
CpG Site-Based Signature Predicts Survival of Colorectal Cancer
Jiande Wu et al.
BIOMEDICINES (2022)
Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer
Zijian Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Global colorectal cancer burden in 2020 and projections to 2040
Yue Xi et al.
TRANSLATIONAL ONCOLOGY (2021)
Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer
Hao Huang et al.
MOLECULAR CARCINOGENESIS (2021)
A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer
Dong-hai Li et al.
CANCER GENETICS (2021)
A panel of differentially methylated regions enable prognosis prediction for colorectal cancer
Lei Zhang et al.
GENOMICS (2021)
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Gerhard Jung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
A novel CpG-methylation-based nomogram predicts survival in colorectal cancer
Xiaokang Wang et al.
EPIGENETICS (2020)
Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling
Zuojing Yin et al.
FRONTIERS IN GENETICS (2020)
Identification of epigenetic methylation-driven signature and risk loci associated with survival for colon cancer
Xiaoyuan Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Gastrointestinal adenocarcinoma analysis identifies promoter methylation-based cancer subtypes and signatures
Renshen Xiang et al.
SCIENTIFIC REPORTS (2020)
The Development of Three-DNA Methylation Signature as a Novel Prognostic Biomarker in Patients with Colorectal Cancer
Shu Gong et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier)
Melanie Guendert et al.
GUT (2019)
Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study
Jihoon E. Joo et al.
GUT (2019)
Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer
Sonja Neumeyer et al.
EPIGENETICS (2019)
A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival
Min Jia et al.
CLINICAL EPIGENETICS (2019)
PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2019)
Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma
Cheng Shi et al.
FRONTIERS IN GENETICS (2019)
Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients
Changshun Yang et al.
AGING-US (2019)
Genome-Wide Network-Based Analysis of Colorectal Cancer Identifies Novel Prognostic Factors and an Integrative Prognostic Index
Xiaolin Hou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
ChAMP: updated methylation analysis pipeline for Illumina BeadChips
Yuan Tian et al.
BIOINFORMATICS (2017)
Survival analysis in the presence of competing risks
Zhongheng Zhang
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Profiling genome-wide DNA methylation
Wai-Shin Yong et al.
EPIGENETICS & CHROMATIN (2016)
DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer
Yutaka Hashimoto et al.
EPIGENOMICS (2016)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2015)
Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment
Michael Hoffmeister et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment
Michael Hoffmeister et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Reduced Risk of Colorectal Cancer Up to 10 Years After Screening, Surveillance, or Diagnostic Colonoscopy
Hermann Brenner et al.
GASTROENTEROLOGY (2014)
STABILITY INVESTIGATIONS OF MULTIVARIABLE REGRESSION MODELS DERIVED FROM LOW- AND HIGH-DIMENSIONAL DATA
Willi Sauerbrei et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2011)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)